Most Popular | BioMedReports.com

Delcath Receives Orphan Drug Designation From FDA For Melphalan; Exelixis Up 50% After Meteroric METEOR Results

Print

E-mail

By Mary Davila
Monday, 20 July 2015 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 20, 2015.
Read more...

Bristol-Myers' HIV-1 Drug Approved In Europe; St. Jude Medical Receives FDA Approval for the Spinal Cord Stimulation Trial System

Print

E-mail

By David Fowler
Thursday, 16 July 2015 23:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 16, 2015.
Read more...

Argos Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT of AGS-003; Ocata Receives New U.S. Patent for Its RPE Therapy

Print

E-mail

By William Kent
Wednesday, 15 July 2015 19:16
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 15, 2015.
Read more...

Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug; Ohr Pharma Announces Positive Results of a Phase II Clinical Study for OHR-102

Print

E-mail

By Marilyn Mullen
Monday, 13 July 2015 21:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 13, 2015.
Read more...

IGI Labs Announces FDA Approval And Commercial Launch Of Diclofenac Sodium; Dynavax to Continue Phase 3 Study of HEPLISAV-B(TM)

Print

E-mail

By Josh Gee
Thursday, 09 July 2015 19:12
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 9, 2015.
Read more...

Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant; Summit Therapeutics Receives FDA Fast Track Designation for SMT19969

Print

E-mail

By William Kent
Wednesday, 08 July 2015 19:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 8, 2015.
Read more...

pSivida Announces Top-Line Results from Phase II Study of Medidur; Esperion Announces Removal of Partial Clinical Hold for ETC-1002

Print

E-mail

By David Fowler
Tuesday, 07 July 2015 18:54
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 7, 2015.
Read more...

Ignyta Announces Collaboration with UCSF For Clinical Trial of Entrectinib; Strensiq Receives Marketing Approval for Hypophosphatasia

Print

E-mail

By Josh Gee
Monday, 06 July 2015 19:57
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2015.
Read more...

Goldman Comments On Vertex After FDA Approval; Arrowhead Initiates Dosing of ARC-AAT in Patients

Print

E-mail

By William Kent
Thursday, 02 July 2015 22:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2015.
Read more...

Gilead Submits NDA to FDA for Single Tablet Regimen for HIV; CEL-SCI Reports June Patient Enrollment

Print

E-mail

By David Fowler
Wednesday, 01 July 2015 20:02
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 1, 2015.
Read more...

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 6 of 369

Newsletter